-
Mashup Score: 0FDA Safety Announcement - 6 day(s) ago
The FDA is providing this communication to increase awareness of recent updates to the product labeling of capecitabine and fluorouracil (5-FU).
Source: www.fda.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0JE Bakery 2019 LLC DBA Broadway Bakery Issues Allergy Alert for Mislabeled Raisin Bran Muffin 6 Count Due to Undeclared Walnuts - 6 day(s) ago
JE Bakery 2019, LLC, Minneapolis MN is voluntarily recalling its Raisin Bran Muffin 6 count due to a labeling error. The affected product was mislabeled and instead contains Glorious Morning Muffins, which contains Walnuts, a known allergen not declared on the label.
Source: www.fda.govCategories: General Medicine News, Allergy-ImmunologyTweet-
JE Bakery 2019 LLC DBA Broadway Bakery Issues Allergy Alert for Mislabeled Raisin Bran Muffin 6 Count Due to Undeclared Walnuts https://t.co/OLUhkAjPPa
-
-
Mashup Score: 43FDA approves brentuximab vedotin with lenalidomide and rituximab - 11 day(s) ago
On February 11, 2025, the FDA approved brentuximab vedotin (Adcetris, Seagen Inc., a subsidiary of Pfizer) in combination with lenalidomide and rituximab.
Source: www.fda.govCategories: General Medicine News, Oncologists1Tweet-
FDA approves brentuximab vedotin with lenalidomide and rituximab for relapsed or refractory large B-cell lymphoma https://t.co/Ibhyzm5v2L #OCENewsBurst
-
-
Mashup Score: 43FDA approves brentuximab vedotin with lenalidomide and rituximab - 11 day(s) ago
On February 11, 2025, the FDA approved brentuximab vedotin (Adcetris, Seagen Inc., a subsidiary of Pfizer) in combination with lenalidomide and rituximab.
Source: www.fda.govCategories: General Medicine News, Oncologists1Tweet-
FDA approves brentuximab vedotin with lenalidomide and rituximab for relapsed or refractory large B-cell lymphoma https://t.co/Ibhyzm5v2L #OCENewsBurst
-
-
Mashup Score: 43FDA approves brentuximab vedotin with lenalidomide and rituximab - 11 day(s) ago
On February 11, 2025, the FDA approved brentuximab vedotin (Adcetris, Seagen Inc., a subsidiary of Pfizer) in combination with lenalidomide and rituximab.
Source: www.fda.govCategories: General Medicine News, Oncologists1Tweet-
FDA approves brentuximab vedotin with lenalidomide and rituximab for relapsed or refractory large B-cell lymphoma https://t.co/Ibhyzm5v2L #OCENewsBurst
-
-
Mashup Score: 7
On February 11, 2025, the Food and Drug Administration approved mirdametinib (Gomekli, SpringWorks Therapeutics, Inc.), a kinase inhibitor, for adult and pediatric patients 2 years of age and older with neurofibromatosis type 1 (NF1) who have symptomatic plexiform neurofibromas (PN) not amenable to
Source: www.fda.govCategories: General Medicine News, Oncologists1Tweet-
The @US_FDA approved the kinase inhibitor mirdametinib for adult and pediatric patients 2 years of age and older with neurofibromatosis type 1 who have symptomatic, inoperable plexiform neurofibromas: https://t.co/eIfcOuJh8O
-
-
Mashup Score: 17
On February 11, 2025, the Food and Drug Administration approved mirdametinib (Gomekli, SpringWorks Therapeutics, Inc.), a kinase inhibitor, for adult and pediatric patients 2 years of age and older with neurofibromatosis type 1 (NF1) who have symptomatic plexiform neurofibromas (PN) not amenable to
Source: www.fda.govCategories: General Medicine News, Oncologists1Tweet-
FDA approves mirdametinib for adult and pediatric patients with neurofibromatosis type 1 who have symptomatic plexiform neurofibromas not amenable to complete resection https://t.co/HVZMVfpRnC #OCENewsBurst
-
-
Mashup Score: 0Recall: Sentec/Percussionaire Removes Phasitron for Malfunctions - 13 day(s) ago
Phasitron Breathing Circuits support continuous ventilation. A malfunctioning venturi component in the circuit may cause reduced oxygen flow.
Source: www.fda.govCategories: General Medicine News, General HCPsTweet-
Breathing Circuit Kit Recall: Sentec/Percussionaire Removes VDR-4 Phasitron Breathing Circuits Due to Venturi Component Malfunctions that May Reduce Pressure and Volume Flow https://t.co/9sLb15oPlB https://t.co/bU4fxiWNG1
-
-
Mashup Score: 0
This communication is part of the Communications Pilot to Enhance the Medical Device Recall Program
Source: www.fda.govCategories: General Medicine News, General HCPsTweet-
Early Alert: Atherectomy Catheter System Issue from Bard Peripheral Vascular https://t.co/Pvi89GeJv0 https://t.co/YAJYFKfYmQ
-
-
Mashup Score: 0Systemic Symptoms in Women with Breast Implants - 16 day(s) ago
Medical Device Reports (MDRs) about systemic symptoms or breast implant illness.
Source: www.fda.govCategories: General Medicine News, General HCPsTweet-
The FDA’s Latest Updates on Breast Implant Safety and Effectiveness https://t.co/6DLRssq4Rh https://t.co/ADhPP3ycdW
-
Important safety milestone https://t.co/P83l1XZ77n